ERG and FLI1 are useful immunohistochemical markers in phosphaturic mesenchymal tumors.

Tajima, Shogo; Takashi, Yuichi; Ito, Nobuaki; Fukumoto, Seiji; Fukuyama, Masashi

Tajima, Shogo; Takashi, Yuichi; Ito, Nobuaki; Fukumoto, Seiji; Fukuyama, Masashi.

Afiliação

Tajima S; Department of Pathology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. stajima-tky@umin.ac.jp.
Takashi Y; Division of Nephrology and Endocrinology, The University of Tokyo Hospital, Tokyo, Japan.
Ito N; Fujii Memorial Institute of Medical Sciences, Tokushima University, Tokushima, Japan.
Fukumoto S; Division of Nephrology and Endocrinology, The University of Tokyo Hospital, Tokyo, Japan.
Fukuyama M; Fujii Memorial Institute of Medical Sciences, Tokushima University, Tokushima, Japan.

Med Mol Morphol ; 49(4): 203-209, 2016 Dec.

Article em En | MEDLINE | ID: mdl-26122367

Assuntos

Biomarcadores Tumorais/metabolismo; Hipofosfatemia Familiar/patologia; Mesoderma/patologia; Neoplasias/metabolismo; Neoplasias/patologia; Proteína Proto-Oncogênica c-fli-1/metabolismo; Adulto; Idoso; Feminino; Humanos; Hipofosfatemia Familiar/metabolismo; Imuno-Histoquímica; Masculino; Mesoderma/metabolismo; Pessoa de Meia-Idade; Regulador Transcricional ERG/metabolismo

Palavras-chave

CD31; CD34; ERG; FLI1; Phosphaturic mesenchymal tumor

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Proteína Proto-Oncogênica c-fli-1 / Hipofosfatemia Familiar / Mesoderma / Neoplasias Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links